• Agency for Toxic Substances and Disease Registry (ATSDR). (2001). Toxicological profile for asbestos: Update. Atlanta, Centers for Disease Control. Report
• Bianchi, C., Brollo, A. Ramai, L., Bianchi, T. & Giarelli, L. (2001). Asbestos exposure in malignant mesothelioma of the pleura: A survey of 557 cases. Industrial Health, 39: 161-167.  Article
• Bowker, M. (2003). Fatal Deception: The Terrifying True Story of How Asbestos is Killing America. Touchstone Books: New York.
• Brodeur, P. (198). Outrageous Misconduct: The Asbestos Industry On Trial, Pantheon Books: New York.
• Cai, S.X., Zhang, C.H., Zhang, X., & Mornaga, K. (2001). Epidemiology of occupational asbestos-related diseases in China. Industrial Health, 39: 75-83.
• Brunner, T.J., Wick, P., Manser, P., Spohn, P., and al. (November 2006). In vitro cytotoxicity of oxyde nanoparticles: comparison to asbestos, silica, and the effect of particle solubility. Environmental Science and Technology, Vol.40, N° 14: 4374-4381
• Elmes, P. C. (1966). The epidemiology and clinical features of asbestosis and related diseases. Postgraduate Medical Journal, 42(492): 623-635.
• Ghio, A.J., Funkhouser, W., Pugh, C.B., Winters, S., Stonehuerner, A., Roggli, V.L. (2006). Pulmonary Fibrosis and Ferruginous Bodis Associated with Exposure to Synthtic Fibers. Toxicologic Pathology, Volume 34: 723-729.
• Han, JH, Lee, EJ, Lee, JH. et al. (June 2008). Monitoring Multiwalled Carbon Nanotube Exposure in Carbon Nanotube Research Facility. Inhalation Toxicology, 20(8): 741-749. Abstract
• Hansen, K., Mossman, B. T. (1987). Generation of superoxide from alveolar macrophages exposed to asbestiform and nonfibrous particles. Cancer Research, 47: 1681-2180.
• Hiraoka, T., Watanabe, A., Usuma, Y., Mori, T., Kohyama, N. & Takat, A. (2001). An operated case of lung cancer with pleural plagues: Its asbestos bodies, fiber analysis and asbestos exposure. Industrial Health, 39: 194-197. Article
• Kane, A.B., Hurt, R.H. (July 2008). Nanotoxicology: The asbestos analogy revisited. Nature Nanotechnology, 3, 378-379. Article
• Kinnula, V. L. (1999). Oxidant and antioxidant mechanisms of lung disease caused by asbestos fibres. European Respiratory Journal, 14: 706-716.
• Koyama , S., Endo M., Kim Y.A., Hayashi T., Yanagisawa, T., Osaka, K., Koyama, H., Haniu, H., Kuroiwa, N. (2006). Role of systemic T-cells and histopathological aspects after subcutaneous implantation of various carbon nanotubes in mice. Carbon, 44: 1079–1092
• Lieben, J. & Pistawka, H. (1967). Mesothelioma and asbestos exposure. Archives of Environmental Health, 14(4): 559-563.
• Lilienfeld, D. E., Mandel, J. S, et al. (1988). Projection of asbestos related diseases in theUnited States, 1985-2009. I Cancer. British Journal of Industrial Medicine, 45(5): 283-291.
• Lilienfeld, D. E. (1991). Asbestos-associated pleural mesothelioma in school teachers: A discussion of four cases. Annual New York Academy of Sciences, 643: 454-486.
• - NEW - Ludicello, J. and Englehardt, J. D. (2009). A predictive Bayesian dose-response assessment for evaluating the toxicity of carbon nanotubes relative to crocidolite using a proposed emergent model. Human and Ecological Risk Assessment. 15(6): 1168-1186.
• Markowitz, S. B., Morabia, A., et al. (1997). Clinical predictors of mortality from astestosis in the North American Insulator Cohort, 1981-1991. American Journal of Respiratory and Critical Care Medicine, 156(1) 101-108.
• Magnani, C., Dalmasso, P., Biggeri, A., Ivaldi, C., Mirabelli, D. (September 2001). Increased Risk of Malignant Mesothelioma of the Pleura after Residential or Domestic Exposure to Asbestos: A Case-Control Study in Casale Monferrato, Italy. Environmental Health Perspectives, 109: 915-919.
• Morinaga, K., Kishimoto, T., Sakatani, M., Akira, M., Yokoyama, K. & Sera Y. (2001). Asbestos-related lung cancer and mesothelioma in Japan. Industrial Health, 39: 65-74. Article
• Nicholdson, W.J. (2001). The carcinogenicity of chrysotile asbestos”A review. Industrial Health, 39: 57-64. Accessed on March 22, 2006. Article
• Occupational Safety and Health Administration (OSHA). (1994). Medical surveillance guidelines for asbestos--non-mandatory. 29 CFR 1915.1001. App I.
• Park, S. H. & Aust, A. E. (1998). Participation of iron and nitric oxide in the mutagenicity of asbestos in hgprt-, gpt+ Chinese hamster V79 cells. Cancer Research, 58(15 March): 1144-1148.
• Poland, C.A., Duffin, R., Kinloch, I. et al. (2008). Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nature Nanotechnology, Published online: 20 May 2008. Abstract.
• Rahman, Q. (2008). Technological Challenges: Asbestos Past Experiences, Nanoparticles Future Developments. Women in Biotechnology, 237-255. Abstract.
• - NEW - Ryman-Rasmussen, J.P., Cesta, M.F., Brody, A. R., Shipley-Phillips, J.K., Everitt, J. I., Tewskbury, E. W., Moss, O.R., Wong, B. A., Dodd, D. E., Andersen, M.E., Bonner, J.C. (2009). Nature Nanotechnology, 4: 747-751. Abstract.
• Shen, Z., Bosbach, D., Hochella, M .F., Bish, D. L., Williams Jr., M. G., Dodson, R. F. & Aust, A. E. (2000). Using in vitro iron deposition on asbestos to model asbestos bodies formed in human lung. Chemical Research in Toxicology,13 (Sept.): 913-921.
• Stayner, L., Smith, R., et al. (1997). Exposure-response analysis of risk of respiratory disease associated with occupational exposure to chrysotile asbestos. Occupational and Environmental Medicine, 54(9): 646-652.
• Suzuki, Y. (2001). Pathology of human malignant
  mesothelioma—Preliminary analysis of 1,517 mesothelioma cases. Industrial
  Health, 39: 183-185. Article
• Suzuki, Y. & Yuen, S.R. (2001). Asbestos tissue burden study on human malignant mesothelioma. Industrial Health, 39: 150-160. Article
• Takagi, A., Hirose, A., Nishimura, T. (February 2008). Induction of mesothelioma in p53+/- mouse by intraperitoneal application of multi-wall carbon nanotube. The Journal of Toxicological Sciences, 33(1): 105-116. Article
• - NEW - Thurnherr, T., Su, S. S., Diener, L., Weinberg, G., Manswer, P., Pfander, N., Arrigo, R., Schuster, M.E., Wick, P., Krug, H. F. (2009). Comprehensive evaluation of in vitro toxicity of three large-scale produced carbon nanotubes on human Jurkat T cells and a comparison to crocidolite asbestos. Nanotoxicology, 3(4): 319-338. Abstract
• Ueki, A. (2001). Biological effects of asbestos fibers on human cells In Vitroespecially on lymphocytes and neutrophils. Industrial Health, 39: 84-93. Accessed on March 22, 2006. Article
• U.S. Environmental Protection Agency (USEPA). (2001). Asbestos: Hazard Summary. Washington D.C., U.S. Environmental Protection Agency: Office of Air and Radiation.
• Wick, P., Manser, P., Limbach, L. et ali. (January 2007). The degree and kind of agglomeration affect carbon nanotube cytotoxicity. Toxicology Letters, 168(2): 121-131. Abstract.
• Wick, P., Manser, P., Spohn, P., Bruinink, A. (October 2006). In vitro evaluation of possible adverse effects of nanosized materials. Physica Status Solidi (b), 243(13): 3556 - 3560. Abstract.
• Yoshizumi, K., Hori, H., Satoh, T. & Higasi, T. (2001). The trend in airborne asbestos concentrations at plants manufacturing asbestos-containing products in Japan. Industrial Health, 39: 127-131. Article

Last updated November 2009 - Maria Powell